Breo
GSK to explore link between Shingrix and dementia risk in new UK research collaboration
More than 55 million people worldwide are currently living with the neurodegenerative disease
Study reveals GSK’s new recombinant shingles vaccine could reduce dementia risk
Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years
GSK’s shingles vaccine shown to maintain high protection in long-term study
The infectious condition affects up to one in three people globally in their lifetimes
FDA approves Alvotech and Teva’s Simlandi as interchangeable Humira biosimilar
Simlandi is approved to treat multiple indications, including rheumatoid arthritis and Crohn’s disease
Sandoz separates from Novartis as an independent spin-off company
The split allows Sandoz to strengthen its position in generics and biosimilars
CureVac advances ‘promising’ seasonal flu mRNA vaccine to phase 2 development
The mid-stage study of the candidate is expected to begin in the fourth quarter of 2023
NHS extends eligibility for shingles vaccine to almost one million people
Approximately one in four people will develop shingles and the risk increases with age
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
Nearly 500,000 died from an opioid overdose between 1999 and 2019
FDA approves GSK’s Priorix vaccine for measles, mumps and rubella
The vaccine has been approved to use in those aged 12 months and above
Rare cancer specialists Sierra Oncology acquired by GSK for £1.5bn
Unification will help to uphold and progress promising Momelotinib treatment which targets myelofibrosis
GSK and CureVac sign deal with Germany for mRNA COVID-19 vaccines
The agreement is part of a Pandemic Preparedness Contract and means millions of vaccines can be produced at short notice during future public health emergencies
Sandoz launches generic oncology treatment in Europe
Lenalidomide can be used to treat patients with haemato-onocology conditions, following recommendations from recent European Society for Medical Oncology (ESMO) guidelines